XML 37 R28.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Notes to the consolidated financial statements - Revenue from contract with customers (Details) - EUR (€) € in Thousands | 6 Months Ended
--- | ---
Jun. 30, 2022 | Jun. 30, 2021
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | € 44,519 | € 32,425
Research services combined with an IP license |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 31,818 | 27,730
Product |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 431 | 338
Milestone revenues |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 5,321 |
Additional development milestone payments | 10,000 |
Development milestone payment included in contract liabilities | 4,679 |
Research and development services |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 12,270 | 4,357
Belgium | GSK |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 43,041 | 29,335
Germany | Boehringer Ingelheim |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues |  | 2,051
Netherlands | Genmab |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | 892 | 870
Switzerland | CRISPR |  |
Disclosure of disaggregation of revenue from contracts with customers [line items] |  |
Total revenues | € 586 | € 169

X
- Definition The amount of additional development milestone payment received. + References No definition available. + Details
Name: | cvac_AdditionalDevelopmentMilestonePaymentsReceived
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of development milestone payment included in contract liabilities + References No definition available. + Details
Name: | cvac_IfrsDevelopmentMilestonePaymentIncludedInContractLiabilities
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2021-01-01 -Paragraph 113 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2021-01-01 -Paragraph 114 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_ResearchServicesCombinedWithIpLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_IfrsProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_MilestoneRevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_ResearchAndDevelopmentServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_BE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_GlaxosmithklineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_DE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_BoehringerIngelheimMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_NL
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_GenmabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_CH
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_CrisprMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |